Louis Sanquini
Vice President, Life Science Group
Healthagen, CVS Health
Getting Real with RWE
Louis Sanquini, Vice President of the Life Science Group at Healthagen®, is a healthcare innovator and data disruptor, who has been making a difference in the healthcare arena for more than 25 years. He currently leads a team that conducts real-world evidence studies to understand the clinical impact of novel and traditional pharmaceutical products along with cutting-edge technology and digital therapeutics. The work is underpinned by a holistic view of the healthcare landscape.
“I am privileged to work with some of the brightest minds in the healthcare industry who have similar goals,” Lou says. “The need for solutions to healthcare challenges, especially those that effect outcomes and costs, fuels a personal desire to unearth data and revolutionize healthcare.”
Before joining Healthagen, he first worked with the team as the founder of TribecaOutcomes, a company based in his entrepreneurial skillset and passion for information and one designed to contribute to the pharmaceutical industry’s transition from volume to value.
Prior to that, he served as Vice President of Marketing Innovation at QualityHealth (now Sharecare) and led the development of industry offerings, such as QualityConversations, in which data was utilized to identify and engage patients prior to their doctors’ visits and led to significant company growth.
Lou began his career at GlaxoSmithKline (GSK), where he successfully led sales and national accounts teams and moved on to ascending roles in U.S. Marketing, launching and managing multiple brands. At Meda Pharmaceuticals (now Mylan), insights from patient and physician data suggested issues with patient administration of nasal sprays and no time for physicians to demonstrate utilization. Lou helped develop the first voice chip instruction element for more than one million product samples to support the launch of an antihistamine nasal spray, that more than exceeded sales expectations.
Lou currently serves on the advisory boards of Zensights, an organization that collects and disseminates data about agencies, consultancies, and vendors that serve the pharmaceutical industry; and NYC Health Business Leaders, an organization of executives, entrepreneurs, and leaders engaged in New York’s healthcare ecosystem.
